Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Shares withheld for taxes President & CEO gave up 6,493 shares (to pay taxes)
  2. 4 Exercise or conversion EVP, Biodefense Divison acquired 3,467 shares (option exercise)
  3. 4 Open-market sale Director sold 2,350 shares at $33.88 ($79,618)
  4. 4 Open-market sale EVP, Biodefense Divison sold 4,359 shares at $33.96 ($148,032)
  5. 4 Shares withheld for taxes Chairman gave up 1,902 shares (to pay taxes)
  6. 4 Open-market sale EVP, Biodefense Divison sold 11,112 shares at $33.84 ($376,030)
  7. 4 Open-market sale Director sold 14,879 shares at $34.03 ($506,332)
  8. 4 Open-market sale Director sold 14,820 shares at $35.34 ($523,739)
  9. 4 Shares withheld for taxes Chairman gave up 8,416 shares (to pay taxes)
  10. 4/A Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes EVP, Corporate Services Div gave up 4,582 shares (to pay taxes)
  12. 4 Shares withheld for taxes EVP, Biodefense Divison gave up 2,541 shares (to pay taxes)
  13. 4 Shares withheld for taxes President & CEO gave up 17,278 shares (to pay taxes)
  14. 4 Open-market sale Director sold 33,134 shares at $35.42 ($1,173,606)
  15. 4 Grant or award Chairman acquired 26,303 shares (grant or award)
  16. 4 Grant or award EVP, Biodefense Divison acquired 7,759 shares (grant or award)
  17. 4 Grant or award EVP, Corporate Services Divisi acquired 14,780 shares (grant or award)
  18. 4 Grant or award President & CEO acquired 35,471 shares (grant or award)
  19. 4 Open-market sale Director sold 11,520 shares at an average $38.79 ($446,890)
  20. 4 Open-market sale Director sold 21,600 shares at $40.00 ($864,000)

Page 25 of 49 · 970 filings